AR062711A1 - Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad - Google Patents
Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidadInfo
- Publication number
- AR062711A1 AR062711A1 ARP070103969A ARP070103969A AR062711A1 AR 062711 A1 AR062711 A1 AR 062711A1 AR P070103969 A ARP070103969 A AR P070103969A AR P070103969 A ARP070103969 A AR P070103969A AR 062711 A1 AR062711 A1 AR 062711A1
- Authority
- AR
- Argentina
- Prior art keywords
- proteins
- purification
- affinity chromatography
- arginine
- product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
La presente se refiere a métodos para aislar un producto y/o reducir la turbidez y/o impurezas de un fluido de carga que comprende el producto y una o más impurezas al pasar el fluido de carga a través de un medio, seguido por al menos una solucion de lavado que comprende arginina o un derivado de arginina, y recolectar el producto al usar una solucion de elucion. La presente se refiere además a un producto preparado al usar un método corno se describe en la presente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84308406P | 2006-09-08 | 2006-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR062711A1 true AR062711A1 (es) | 2008-11-26 |
Family
ID=39158086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070103969A AR062711A1 (es) | 2006-09-08 | 2007-09-07 | Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad |
Country Status (17)
Country | Link |
---|---|
US (2) | US7714111B2 (es) |
EP (1) | EP2059258B1 (es) |
JP (1) | JP5386354B2 (es) |
KR (1) | KR20090064377A (es) |
CN (1) | CN101511387A (es) |
AR (1) | AR062711A1 (es) |
AU (1) | AU2007292253A1 (es) |
BR (1) | BRPI0716597A2 (es) |
CA (1) | CA2661645C (es) |
CL (1) | CL2007002615A1 (es) |
ES (1) | ES2764222T3 (es) |
IL (1) | IL197053A0 (es) |
MX (1) | MX2009002576A (es) |
PE (1) | PE20080913A1 (es) |
RU (1) | RU2009106083A (es) |
TW (1) | TW200821026A (es) |
WO (1) | WO2008031020A2 (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2655873C (en) * | 2006-07-14 | 2017-10-17 | Wisconsin Alumni Research Foundation | Adsorptive membranes for trapping viruses |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
SG10201510384UA (en) | 2006-09-13 | 2016-01-28 | Abbvie Inc | Cell culture improvements |
DK2089429T3 (en) * | 2006-10-19 | 2015-01-12 | Janssen Biotech Inc | PROCEDURE FOR MANUFACTURING NON-AGGREGATED ANTIBODY-FC DOMAINS |
US8669045B2 (en) * | 2007-02-13 | 2014-03-11 | Ajinomoto Co., Inc. | Method for inactivating viruses with slightly acidic arginine |
MX2011004200A (es) * | 2008-10-20 | 2011-05-24 | Abbott Lab | Aislamento y purificacion de anticuerpos usando la cromatografia de afinidad de proteina a. |
WO2010048192A2 (en) | 2008-10-20 | 2010-04-29 | Abbott Laboratories | Viral inactivation during purification of antibodies |
DK2350271T3 (en) | 2008-11-20 | 2016-04-04 | Biogen Ma Inc | ARGININ INACTIVATION OF ENVIRONMENT VIRA |
EP2406274A2 (en) | 2009-03-11 | 2012-01-18 | Wyeth LLC | Methods of purifying small modular immunopharmaceutical proteins |
EP4328305A3 (en) | 2009-12-18 | 2024-08-14 | CSL Ltd. | Method of purifying polypeptides |
SG10201408384PA (en) * | 2009-12-18 | 2015-01-29 | Novartis Ag | Wash solution and method for affinity chromatography |
ES2492681T3 (es) * | 2010-01-22 | 2014-09-10 | Boehringer Ingelheim International Gmbh | Método cromatográfico para purificar proteínas que contienen FC |
WO2011162210A1 (ja) * | 2010-06-21 | 2011-12-29 | 協和発酵キリン株式会社 | アミノ酸を利用したタンパク質の精製方法 |
EP3428176A1 (en) | 2011-06-01 | 2019-01-16 | Novartis AG | Wash solution and method for affinity chromatography |
WO2013055958A1 (en) | 2011-10-11 | 2013-04-18 | Genentech, Inc. | Improved assembly of bispecific antibodies |
US20130109807A1 (en) * | 2011-10-26 | 2013-05-02 | Bio-Rad Laboratories, Inc. | Removal of virucidal agents in mixed mode chromatography |
TWI596107B (zh) | 2013-06-25 | 2017-08-21 | 卡地拉保健有限公司 | 單株抗體之新穎純化方法 |
KR101414897B1 (ko) * | 2013-11-29 | 2014-07-04 | 씨제이헬스케어 주식회사 | 다베포에틴 알파의 정제 방법 |
CA2962105A1 (en) | 2014-09-24 | 2016-03-31 | Basf Se | Method for producing diesters of terephthalic acid |
EP3197858B1 (de) | 2014-09-24 | 2019-02-06 | Basf Se | Verfahren zur herstellung von terephthalsäurediestern mit umwälzung des reaktionsgemisches |
BR112017005850A2 (pt) | 2014-09-24 | 2018-02-06 | Basf Se | processo e aparelho para preparação de um diéster tereftálico. |
CN106715382A (zh) | 2014-09-24 | 2017-05-24 | 巴斯夫欧洲公司 | 通过再循环醇脱水而制备对苯二甲酸二酯的方法 |
US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
EP3268100A1 (en) | 2015-03-13 | 2018-01-17 | Bristol-Myers Squibb Company | Use of alkaline washes during chromatography to remove impurities |
HRP20160086A2 (hr) | 2016-01-27 | 2017-08-11 | Sveučilište u Zagrebu | Eluens za imunoafinitetnu kromatografiju virusa i proteina |
DE102016106271B4 (de) | 2016-04-06 | 2018-03-29 | Axagarius Gmbh & Co. Kg | Aufreinigung von Nukleinsäure aus einer Nukleinsäure und Endotoxin enthaltenden Probe |
US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
JP7106187B2 (ja) | 2016-05-11 | 2022-07-26 | サイティバ・バイオプロセス・アールアンドディ・アクチボラグ | 分離マトリックスを保存する方法 |
CN109311948B (zh) | 2016-05-11 | 2022-09-16 | 思拓凡生物工艺研发有限公司 | 清洁和/或消毒分离基质的方法 |
US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
EP3455243B1 (en) | 2016-05-11 | 2021-03-24 | Cytiva BioProcess R&D AB | Separation matrix |
US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
KR102359192B1 (ko) * | 2016-07-25 | 2022-02-04 | 세파론, 인코포레이티드 | 친화성 크로마토그래피 세정 완충액 |
JP7058272B2 (ja) * | 2016-09-07 | 2022-04-21 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド | 抗体を精製するための方法 |
AU2018212974B2 (en) * | 2017-01-30 | 2023-08-24 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for reducing bioburden in chromatography |
TW202000891A (zh) * | 2018-03-07 | 2020-01-01 | 英商葛蘭素史克智慧財產發展有限公司 | 純化抗體之方法 |
CN111902720A (zh) | 2018-03-21 | 2020-11-06 | 沃特世科技公司 | 基于非抗体高亲和力的样品制备、吸附剂、装置和方法 |
CN108586606A (zh) * | 2018-04-24 | 2018-09-28 | 上海药明生物技术有限公司 | 一种用于去除抗体蛋白中内毒素的方法 |
US20230143163A1 (en) * | 2020-04-27 | 2023-05-11 | Alexion Pharmaceuticals, Inc. | Protein a chromatography purification of an antibody |
US20230166201A1 (en) * | 2020-05-01 | 2023-06-01 | Kashiv Biosciences, Llc | An improved process of affinity chromatography |
CN113980092B (zh) * | 2021-12-09 | 2024-05-14 | 上海药明生物技术有限公司 | 一种蛋白质亲和纯化方法 |
CN114891061A (zh) * | 2022-04-25 | 2022-08-12 | 杭州艾策生物技术有限公司 | 一种糖基化重组蛋白的纯化方法 |
TW202423945A (zh) * | 2022-12-12 | 2024-06-16 | 丹麥商H 朗德貝克公司 | 蛋白質純化中的精胺酸洗滌 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4010148A (en) | 1975-05-12 | 1977-03-01 | Board Of Regents Of The University Of Texas System | Purified thymosin and process |
IL47645A (en) * | 1975-07-04 | 1980-10-26 | Yeda Res & Dev | Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it |
JPS6030291B2 (ja) * | 1978-03-20 | 1985-07-16 | 森永乳業株式会社 | 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤 |
US4230697A (en) * | 1978-07-03 | 1980-10-28 | Morinaga Milk Industry Co. Ltd. | Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same |
US4624932A (en) | 1978-09-13 | 1986-11-25 | Samuel Bogoch | Recognins and their chemoreciprocals |
EP0009781B2 (en) | 1978-09-29 | 1986-04-23 | Mitsubishi Kasei Corporation | Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby |
JPS5569595A (en) | 1978-11-20 | 1980-05-26 | Suguru Abe | Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation |
CA1172980A (en) | 1979-04-02 | 1984-08-21 | Kenji Takemoto | Pentadecapeptide and process for the preparation thereof |
DE3034529C2 (de) | 1980-09-12 | 1982-09-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel |
DE3110561A1 (de) | 1981-03-18 | 1982-11-04 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Chemorekrutine der leukozyten und des entszuendungsgewebes: eine neue klasse natuerlicher leukopoetine zurselektiven chemorekrutierung von leukozyten aus dem knochenmark in den blutstrom (leukozytose- und linskverschiebungsreaktion) |
DE3110560A1 (de) * | 1981-03-18 | 1982-10-14 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben" |
US4532207A (en) | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
US4390468A (en) | 1982-08-04 | 1983-06-28 | Maruzen Oil Co., Ltd. | Preparation of antitumor agent from shellfish |
US4882421A (en) | 1982-09-23 | 1989-11-21 | Alfacell Corporation | Pharmaceutical for treating tumors and method for making it |
US4568545A (en) * | 1982-10-02 | 1986-02-04 | Amano Seiyaku Kabushiki Kaisha | Thrombolytic agent |
JPS5980613A (ja) | 1982-10-29 | 1984-05-10 | Mitsui Toatsu Chem Inc | 新規なプラスミノ−ゲン・アクチベ−タ及びその製造方法 |
US4880914A (en) | 1982-11-09 | 1989-11-14 | Cornell Research Foundation, Inc. | Assay for qualitatively and/or quantitatively measuring hLH or hCG in body fluids and reagents therefor |
US4966888A (en) | 1985-07-08 | 1990-10-30 | Cornell Research Foundation, Inc. | hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine |
US4639513A (en) | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
GB8314362D0 (en) | 1983-05-24 | 1983-06-29 | Celltech Ltd | Polypeptide and protein products |
US4456676A (en) | 1983-06-10 | 1984-06-26 | E. I. Du Pont De Nemours And Company | Amine stabilizers for wash-off systems |
US4444760A (en) * | 1983-06-17 | 1984-04-24 | Merck & Co., Inc. | Purification and characterization of a protein fibroblast growth factor |
JPS6028999A (ja) * | 1983-06-30 | 1985-02-14 | Maruho Kk | 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法 |
JPS60184098A (ja) * | 1984-03-02 | 1985-09-19 | Suntory Ltd | 新規なペプチド及びこれを有効成分とする利尿剤 |
JPH0794473B2 (ja) | 1984-03-02 | 1995-10-11 | サントリー株式会社 | 新規なペプチド及びこれを有効成分とする利尿剤 |
US4670539A (en) | 1984-07-27 | 1987-06-02 | Board Of Regents, The University Of Texas | Peptide growth factors derived from estrogen responsive kidney tissue |
US5132214A (en) | 1986-04-09 | 1992-07-21 | Monsanto Company | Large scale production of plasminogen activator from normal human colon cells |
US5030559A (en) | 1986-04-01 | 1991-07-09 | Board Of Regents, The University Of Texas System | Methods and compositions for the identification of metastatic human tumors |
US5213970A (en) | 1987-01-23 | 1993-05-25 | Board Of Regents, The University Of Texas System | Method for obtaining soluble antitumor factor |
US5162507A (en) | 1987-05-11 | 1992-11-10 | Cetus Corporation | Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
EP0317376B2 (fr) * | 1987-10-23 | 1996-04-03 | Centre Regional De Transfusion Sanguine De Lille | Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques |
JPH01238534A (ja) * | 1988-03-17 | 1989-09-22 | Mitsui Toatsu Chem Inc | エンドトキシンの除去方法 |
US5760183A (en) | 1989-02-17 | 1998-06-02 | Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques | Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same |
DE3914354C1 (es) | 1989-04-29 | 1990-10-31 | Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De | |
DK165090D0 (da) | 1990-07-09 | 1990-07-09 | Kem En Tec As | Konglomererede partikler |
FR2676231A1 (fr) * | 1991-05-07 | 1992-11-13 | Aetsrn | Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation. |
JPH0518950A (ja) | 1991-07-09 | 1993-01-26 | Showa Denko Kk | アフイニテイクロマトグラフイー用吸着担体 |
DE59208181D1 (de) | 1991-12-18 | 1997-04-17 | Hoechst Ag | Verfahren zur Gewinnung von insulinhaltigen Lösungen |
US5372942A (en) | 1992-02-10 | 1994-12-13 | Coriell Institute For Medical Research | Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent |
CH685498A5 (fr) * | 1992-02-14 | 1995-07-31 | Om Lab Sa | Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait. |
JP2767521B2 (ja) | 1992-09-04 | 1998-06-18 | 農林水産省食品総合研究所長 | 新規抗腫瘍性蛋白質とその製造法および該蛋白質を有効成分として含有する抗腫瘍剤 |
JP3801196B2 (ja) | 1993-03-09 | 2006-07-26 | ジェンザイム・コーポレイション | 乳からの対象化合物の単離 |
US5710126A (en) * | 1993-03-12 | 1998-01-20 | Immulogic Pharmaceutical Corporation | T cell epitopes of ryegrass pollen allergen |
US6607884B1 (en) | 1993-03-19 | 2003-08-19 | The Johns Hopkins University School Of Medicine | Methods of detecting growth differentiation factor-8 |
US5332503A (en) | 1993-04-16 | 1994-07-26 | Baxter International Inc. | Process for purifying collagenase |
US5330972A (en) | 1993-05-28 | 1994-07-19 | Abbott Laboratories | Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus |
JP2971293B2 (ja) | 1993-06-11 | 1999-11-02 | 株式会社細菌化学研究所 | 溶血性連鎖球菌の産生する生理活性物質及びその製造法 |
US5500413A (en) | 1993-06-29 | 1996-03-19 | Ferring Ab | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
US5478924A (en) | 1994-02-16 | 1995-12-26 | Cramer; Steven M. | Displacement chromatography of proteins using low molecular weight displacers |
US5570389A (en) | 1994-06-30 | 1996-10-29 | Compaq Computer Corporation | Method for reliable exchange of modem handshaking information over a cellular radio carrier |
US5659017A (en) | 1995-11-07 | 1997-08-19 | Alpha Therapeutic Corporation | Anion exchange process for the purification of Factor VIII |
DE19600939C1 (de) * | 1996-01-12 | 1997-08-28 | Immuno Ag | Verfahren zur Trennung von IgG und IgA |
SE9603068D0 (sv) | 1996-08-23 | 1996-08-23 | Pharmacia & Upjohn Ab | Process for purifying a protein |
SI0950067T1 (sl) * | 1996-11-27 | 2007-12-31 | Genentech Inc | Afinitetno čiščenje polipeptida na proteinskemA matriksu |
ZA9711580B (en) | 1996-12-25 | 1999-09-23 | Hoechst Marion Roussel Ltd | Process for the production of purified dimeric bone morphogenetic factors. |
GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
US6451260B1 (en) * | 1997-08-26 | 2002-09-17 | Dyax Corp. | Method for producing microporous elements, the microporous elements thus produced and uses thereof |
US20030036629A1 (en) * | 1997-12-12 | 2003-02-20 | Barry Foster | Novel tgf-beta protein purification methods |
US6673629B2 (en) * | 1998-01-15 | 2004-01-06 | Abbott Laboratories | Neutralization of polycations in a chromatographic device for whole blood use |
DE19937219A1 (de) | 1999-08-06 | 2001-02-08 | Aventis Behring Gmbh | Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie |
AU3959499A (en) | 1998-05-28 | 1999-12-13 | Korea Green Cross Corporation | Process of purifying angiogenesis inhibitors |
ES2527915T3 (es) * | 1998-06-09 | 2015-02-02 | Csl Behring Ag | Producto de inmunoglobulina G (IgG) líquido |
GB9815666D0 (en) | 1998-07-17 | 1998-09-16 | Smithkline Beecham Plc | Novel compounds |
RU2143492C1 (ru) | 1998-07-23 | 1999-12-27 | Навашин Петр Сергеевич | Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека |
RU2144082C1 (ru) | 1998-07-23 | 2000-01-10 | Навашин Петр Сергеевич | Рекомбинантная плазмида, кодирующая гибридный белок-предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка-предшественника инсулина человека (варианты) и способ получения инсулина человека |
US7198896B2 (en) | 1998-09-04 | 2007-04-03 | Cell Signaling Technology, Inc. | Immunoaffinity isolation of modified peptides from complex mixtures |
US7300753B2 (en) * | 1998-09-04 | 2007-11-27 | John Rush | Immunoaffinity isolation of modified peptides from complex mixtures |
US7307161B1 (en) | 1999-04-28 | 2007-12-11 | Genetics Institute, Llc | Human Gil-19/AE289 polynucleotides |
US6939545B2 (en) | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
DE19937218A1 (de) | 1999-08-06 | 2001-02-08 | Aventis Behring Gmbh | Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie |
US6774102B1 (en) * | 1999-09-29 | 2004-08-10 | Gambro Dialysatoren Gmbh & Co. Kg | Extracorporeal endotoxin removal method |
PT1226269E (pt) | 1999-11-04 | 2003-11-28 | Genentech Inc | Ensaio de hplc de fase reversa para activadores de plasminogenio |
US6825164B1 (en) * | 2000-08-14 | 2004-11-30 | The Trustees Of Columbia University In The City Of New York | Method to increase cerebral blood flow in amyloid angiopathy |
DE10046960A1 (de) | 2000-09-22 | 2002-04-11 | Roche Diagnostics Gmbh | Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen |
US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
US20030133939A1 (en) * | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
US7638604B2 (en) * | 2001-02-23 | 2009-12-29 | Genetics Institute, Llc | Monoclonal antibodies against interleukin-22 |
US20040058445A1 (en) * | 2001-04-26 | 2004-03-25 | Ledbetter Jeffrey Alan | Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB |
CA2448788C (en) * | 2001-06-05 | 2010-08-24 | Genetics Institute, Llc. | Methods for purifying highly anionic proteins |
AU2002327795A1 (en) | 2001-10-09 | 2003-04-22 | The Government Of The United States Of America, As Represented By The Department Of Health And Human | Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb) |
US20040161776A1 (en) * | 2001-10-23 | 2004-08-19 | Maddon Paul J. | PSMA formulations and uses thereof |
AU2003212912A1 (en) * | 2002-02-04 | 2003-09-02 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
AU2003210802B2 (en) | 2002-02-05 | 2009-09-10 | Genentech Inc. | Protein purification |
WO2004000220A2 (en) | 2002-06-21 | 2003-12-31 | Genetix Pharmaceuticals, Inc. | Methods for purifying viral particles for gene therapy |
AR047392A1 (es) * | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
DK1678208T3 (da) * | 2003-10-27 | 2013-07-08 | Wyeth Llc | Fjernelse af aggregater med høj molekylvægt under anvendelse af hydroxyapatitchromatografi |
US7065110B2 (en) * | 2004-01-20 | 2006-06-20 | Northrop Grumman Corporation | Scalable wavelength shifted laser source and method |
US8084032B2 (en) * | 2004-01-21 | 2011-12-27 | Ajinomoto Co., Inc. | Purification method which prevents denaturation of an antibody |
US7501121B2 (en) * | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
AR049390A1 (es) | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
ES2797480T3 (es) * | 2005-03-11 | 2020-12-02 | Wyeth Llc | Un procedimiento de cromatografía de reparto débil |
-
2007
- 2007-09-07 ES ES07814753T patent/ES2764222T3/es active Active
- 2007-09-07 EP EP07814753.5A patent/EP2059258B1/en not_active Revoked
- 2007-09-07 TW TW096133471A patent/TW200821026A/zh unknown
- 2007-09-07 KR KR1020097004828A patent/KR20090064377A/ko not_active Application Discontinuation
- 2007-09-07 AU AU2007292253A patent/AU2007292253A1/en not_active Abandoned
- 2007-09-07 US US11/899,955 patent/US7714111B2/en active Active
- 2007-09-07 CA CA2661645A patent/CA2661645C/en active Active
- 2007-09-07 WO PCT/US2007/077865 patent/WO2008031020A2/en active Application Filing
- 2007-09-07 AR ARP070103969A patent/AR062711A1/es unknown
- 2007-09-07 CL CL200702615A patent/CL2007002615A1/es unknown
- 2007-09-07 PE PE2007001208A patent/PE20080913A1/es not_active Application Discontinuation
- 2007-09-07 RU RU2009106083/15A patent/RU2009106083A/ru unknown
- 2007-09-07 BR BRPI0716597-8A2A patent/BRPI0716597A2/pt not_active Application Discontinuation
- 2007-09-07 CN CNA2007800329854A patent/CN101511387A/zh active Pending
- 2007-09-07 JP JP2009527581A patent/JP5386354B2/ja active Active
- 2007-09-07 US US11/899,972 patent/US8350013B2/en active Active
- 2007-09-07 MX MX2009002576A patent/MX2009002576A/es not_active Application Discontinuation
-
2009
- 2009-02-15 IL IL197053A patent/IL197053A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2009002576A (es) | 2009-03-20 |
US20080064861A1 (en) | 2008-03-13 |
ES2764222T3 (es) | 2020-06-02 |
RU2009106083A (ru) | 2010-10-20 |
JP2010502737A (ja) | 2010-01-28 |
IL197053A0 (en) | 2009-11-18 |
PE20080913A1 (es) | 2008-08-21 |
CA2661645C (en) | 2016-11-08 |
EP2059258A4 (en) | 2012-05-02 |
EP2059258A2 (en) | 2009-05-20 |
KR20090064377A (ko) | 2009-06-18 |
CN101511387A (zh) | 2009-08-19 |
TW200821026A (en) | 2008-05-16 |
US7714111B2 (en) | 2010-05-11 |
WO2008031020A2 (en) | 2008-03-13 |
US8350013B2 (en) | 2013-01-08 |
WO2008031020A3 (en) | 2008-10-23 |
EP2059258B1 (en) | 2019-11-13 |
CA2661645A1 (en) | 2008-03-13 |
AU2007292253A1 (en) | 2008-03-13 |
BRPI0716597A2 (pt) | 2013-10-08 |
CL2007002615A1 (es) | 2008-04-18 |
US20080064860A1 (en) | 2008-03-13 |
JP5386354B2 (ja) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR062711A1 (es) | Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad | |
AR062570A1 (es) | Proceso para la purificacion de las proteinas que contienen fc | |
AR069097A1 (es) | Purificacion de anticuerpos por cromatografia de intercambio cationico | |
UY31789A1 (es) | Composiciones de insulina de super rápida actuación | |
WO2007109163A3 (en) | Wash buffer and method of using | |
MX2012007103A (es) | Solucion y metodo de lavado por cromatografia de afinidad. | |
AR086525A1 (es) | Metodo de purificacion de anticuerpos | |
AR063587A1 (es) | Preparcion liquida que comprende pimobendan | |
MEP44608A (en) | Methods for treating infectious disease exacerbated asthma | |
SG149759A1 (en) | Media for affinity chromatography | |
SG10201908027QA (en) | Use of alkaline washes during chromatography to remove impurities | |
SG194460A1 (en) | Wash solution and method for affinity chromatography | |
WO2009123764A3 (en) | Compositions and use of epas1 inhibitors | |
NZ590257A (en) | Method of preparing alpha-1 proteinase inhibitor | |
TR201911082T4 (tr) | K vitaminine bağımlı proteinlerin saflaştırılması için bir işlem. | |
ES2674177T3 (es) | Preparación de suero | |
DE602008006254D1 (de) | Doppel-oligonukleotid-nukleinsäurenachweisverfahren | |
BR112014000522A2 (pt) | meio de cultura, método para cultivar salmonella e e. coli e método para detectar salmonella e e. coli | |
CL2007003659A1 (es) | Kit de deteccion de microorganismos patogenos mediante pruebas de aliento. | |
MY157846A (en) | Process for the purification of fc-containing proteins | |
EA200970074A1 (ru) | Химический способ создания давления | |
MX2013013224A (es) | Procedimiento de purificacion de proteinas de bajo ph. | |
MX2014003415A (es) | Mediadores azo. | |
FR3024142B1 (fr) | Procede de purification de glycol utilise comme agent anti-hydrate | |
FR2936438B1 (fr) | Dispositif d'usinage destine au polissage de chants, permettant une automatisation complete de l'operation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |